Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Depreotide
Drug ID BADD_D00610
Description Depreotide is an ingredient in the EMA-withdrawn product NeoSpect.
Indications and Usage Not Available
Marketing Status withdrawn
ATC Code Not Available
DrugBank ID DB11628
KEGG ID D03687
MeSH ID C444119
PubChem ID 9898619
TTD Drug ID Not Available
NDC Product Code Not Available
UNII NDP0H8E844
Synonyms technetium Tc 99m depreotide | Tc-99m depreotide | NeoTec
Chemical Information
Molecular Formula C65H96N16O12S2
CAS Registry Number 161982-62-3
SMILES CC(C)C1C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32 )CC4=CC=C(C=C4)O)CC5=CC=CC=C5)C)CCSCC(=O)NCC(C(=O)NC(CCCCN)C(=O)NC(CS)C(=O)NC(CC CCN)C(=O)N)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Asthenia08.01.01.001--Not Available
Diarrhoea07.02.01.001--
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.003--
Fatigue08.01.01.002--
Flushing23.06.05.003; 08.01.03.025; 24.03.01.002--
Gastrointestinal pain07.01.05.005--
Headache17.14.01.001--
Nausea07.01.07.001--
Vomiting07.01.07.003--
The 1th Page    1    Total 1 Pages